sj-xlsx-2-tae-10.1177_20420188211044945 – Supplemental material for Effects of SGLT2 inhibitors on cardiovascular death and all-cause death in patients with type 2 diabetes and chronic kidney disease: an updated meta-analysis including the SCORED trial

Name: sj-xlsx-2-tae-10.1177_20420188211044945 – Supplemental material for Effects of SGLT2 inhibitors on cardiovascular death and all-cause death in patients with type 2 diabetes and chronic kidney disease: an updated meta-analysis including the SCORED trial
Creator: SAGE Journals
Published: 2024-08-28 09:25:17
License: 暂无描述

DataCite Commons2024-08-28 更新2025-04-16 收录

下载链接：

https://sage.figshare.com/articles/dataset/sj-xlsx-2-tae-10_1177_20420188211044945_Supplemental_material_for_Effects_of_SGLT2_inhibitors_on_cardiovascular_death_and_all-cause_death_in_patients_with_type_2_diabetes_and_chronic_kidney_disease_an_updated_meta-analysis_including_the_SCO/16676903/1

下载链接

链接失效反馈

官方服务：

资源简介：

Supplemental material, sj-xlsx-2-tae-10.1177_20420188211044945 for Effects of SGLT2 inhibitors on cardiovascular death and all-cause death in patients with type 2 diabetes and chronic kidney disease: an updated meta-analysis including the SCORED trial by Li-Min Zhao, Ze-Lin Zhan and Mei Qiu in Therapeutic Advances in Endocrinology and Metabolism

补充材料sj-xlsx-2-tae-10.1177_20420188211044945，对应论文《2型糖尿病合并慢性肾脏病患者使用钠-葡萄糖协同转运蛋白2（SGLT2）抑制剂对心血管死亡及全因死亡的影响：一项纳入SCORED试验的更新荟萃分析》，该论文由赵利民、詹泽林、邱美撰写，发表于《内分泌与代谢治疗进展》（Therapeutic Advances in Endocrinology and Metabolism）

提供机构：

SAGE Journals

创建时间：

2021-09-24